Diagnostic Evaluation of HIV-Associated Acute Kidney Injury

Authored by Sourabh Sharma, published on 2026-11-18 17:35:58.0

  1. Confirmed HIV With Suspected AKI
    • Reconstruct Baseline; Confirm KDIGO AKI by SCr ≥0.3/48 Hours, ≥1.5×/7 Days, or Urine Output <0.5 mL/kg/h for 6 Hours
      • KDIGO AKI Confirmed?
        • Stage KDIGO AKI and Identify Shock, Obstruction, or Dialysis Indications
          • Stabilize Patient, Treat Emergencies, and Relieve Urgent Obstruction
            • Obtain Basic Panel: Haemodynamics, CBC/Chemistry, ART/Drugs, CD4, HIV RNA, OI Screen, Urine Phenotype, and Ultrasound
              • Is Creatinine Rise Isolated After Secretion-Inhibiting Drug Initiation?
                • Verify Pseudo-AKI With Cystatin C or Measured GFR
                • Classify Renal Phenotypes and Follow All Applicable Branches
                  • Evaluate Volume Loss, Sepsis, Cardiorenal, Hepatorenal, and Haemodynamic Causes
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                  • Test Proximal Tubular Function, CK, and Nephrotoxin Exposure
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                  • Quantify Protein Pattern; Test HIVAN, Immune-Complex, Infection-Related, and Conventional GN
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                  • Review Drugs; Evaluate AIN, Crystals, OIs, and IRIS
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                  • Confirm MAHA; Evaluate HIV-TMA, DIC, Sepsis, and Malignancy
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                  • Image Urinary Tract; Evaluate Stones, Infection, and Infiltrative Disease
                    • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                      • Etiology Sufficiently Established After Initial Response?
                        • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                        • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                          • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                            • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                              • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                                • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                  • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                                • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                              • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
          • Obtain Basic Panel: Haemodynamics, CBC/Chemistry, ART/Drugs, CD4, HIV RNA, OI Screen, Urine Phenotype, and Ultrasound
            • Is Creatinine Rise Isolated After Secretion-Inhibiting Drug Initiation?
              • Verify Pseudo-AKI With Cystatin C or Measured GFR
              • Classify Renal Phenotypes and Follow All Applicable Branches
                • Evaluate Volume Loss, Sepsis, Cardiorenal, Hepatorenal, and Haemodynamic Causes
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                • Test Proximal Tubular Function, CK, and Nephrotoxin Exposure
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                • Quantify Protein Pattern; Test HIVAN, Immune-Complex, Infection-Related, and Conventional GN
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                • Review Drugs; Evaluate AIN, Crystals, OIs, and IRIS
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                • Confirm MAHA; Evaluate HIV-TMA, DIC, Sepsis, and Malignancy
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                • Image Urinary Tract; Evaluate Stones, Infection, and Infiltrative Disease
                  • Overlay CD4, HIV RNA, OI, IRIS, and Drug Timing; Correct Reversible Causes
                    • Etiology Sufficiently Established After Initial Response?
                      • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
                      • Refer to a Tertiary Nephrology Centre for Advanced Evaluation
                        • Perform Advanced Phenotype-Directed Serology, Microbiology, Tubular Testing, Imaging, and Expert Microscopy
                          • Would Kidney Biopsy Resolve Unexplained AKI or Change Management?
                            • Are Bleeding, Blood Pressure, and Procedural Risks Acceptable?
                              • Obtain Kidney Biopsy With LM, IF, EM, and Pathogen Studies
                                • Assign Concurrent HIVAN, Immune-Complex, Tubular, Interstitial, Vascular, and Infiltrative Lesions
                              • Correct Biopsy Precautions or Use an Alternative Diagnostic Strategy
                            • Assign All Concurrent AKI Etiologies and Direct Cause-Specific Care
        • Evaluate CKD, Pseudo-AKI, or Nonrenal Creatinine Elevation
tosprivacy